Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Perlis, R. H. Articles by Fava, M. Search for Related Content PubMed Citation Articles by Perlis, R. H. Articles by Fava, M. Depression

Effect of Medical Comorbidity on Response to Fluoxetine Augmentation or Dose Increase in Outpatients With Treatment-Resistant Depression

Received Jan. 9, 2003; revision received Oct. 10, 2003; accepted Nov. 7, 2003. From the Depression Clinical and Research Program, Massachusetts General Hospital; and the Department of Psychiatry, Harvard Medical School, Boston. Address reprint requests to Dr. Perlis, Depression Clinical and Research Program, Massachusetts General Hospital, WACC 812, 15 Parkman St., Boston, MA 02114; rperlis{at}partners.org (e-mail).

This study assessed the effect of general medical comorbidity on response to next-step antidepressant treatments among subjects with major depressive disorder whose depression failed to respond to an 8-week open trial of 20 mg/day of fluoxetine. Of the 386 outpatients in the open trial, 101 who remained depressed were randomly assigned to double-blind treatment with either an increased dose of fluoxetine or lithium or desipramine augmentation for 4 weeks. The Cumulative Illness Rating Scale (CIRS) was used to assess baseline general medical comorbidity, and the Hamilton Depression Rating Scale was used to assess depressive symptoms. Logistic regression analysis showed that CIRS score was not associated with likelihood of remission or premature study discontinuation. Medical comorbidity thus does not appear to be associated with significantly poorer outcome among patients whose major depressive disorder failed initially to respond to an initial trial of 20 mg/day of fluoxetine.

This article has been cited by other articles:

				A. J. Mitchell and H. Subramaniam Prognosis of Depression in Old Age Compared to Middle Age: A Systematic Review of Comparative Studies Am J Psychiatry, September 1, 2005; 162(9): 1588 - 1601. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us